Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

Listen Now

Topics Covered

• What is Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation?
• Understanding How GVHD Develops, Including Finding GVHD Early, in the Context of COVID-19 & Its Variants
• Common Signs and Symptoms of GVHD
• Types of GVHD: Chronic and Acute
• Current Standard of Care for Managing GVHD
• New & Promising Treatment Approaches for GVHD
• Clinical Trials: How Research Increases Treatment Options
• The Increasing Role of Telehealth/Telemedicine Appointments
• Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions, Follow-Up Care & Discussion of OpenNotes
• Questions for Our Panel of Experts

Our Panel of Experts

Samer Al-Homsi, MD, MBA

Professor of Clinical Medicine, New York University, Director of Blood and Marrow Transplantation, Perlmutter Cancer Center, NYU Langone Health

Zachariah DeFilipp, MD

Director of BMT Clinical Research, Hematopoietic Cell Transplant & Cellular Therapy Program, Massachusetts General Hospital, Assistant Professor in Medicine, Harvard Medical School

Nandita Khera, MD, MPH

Consultant, Division of Hematology/Oncology Department of Internal Medicine Associate Professor of Medicine College of Medicine, Mayo Clinic

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on April 28, 2022.